Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.083 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2005RANK expression in normal and malignant cells: a monoclonal antibody studyKostakis, P.; Atkins, G.; Vincent, C.; Farrugia, A.; Findlay, D.; Evdokiou, A.; Zannettino, A.; Annual Meeting of the American Society for Bone and Mineral Research (27th : 2005 : Nashville, Tennessee)
2002Evidence for the maturation-dependent expression of an osteoclastogenic phenotype in human osteoblasts.Atkins, G.; Zannettino, A.; Kostakis, P.; Pan, B.; Farrugia, A.; Evdokiou, A.; Findlay, D.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2004Identification and clinical relevance of receptor activator of nuclear factor kappa B ligand expression of myeloma cells - ReplyZannettino, A.; Pan, B.; Farrugia, A.; Atkins, G.; To, L.
2006RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of boneAtkins, G.; Kostakis, P.; Vincent, C.; Farrugia, A.; Houchins, J.; Findlay, D.; Evdokiou, A.; Zannettino, A.
2005Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factorZannettino, A.; Holding, C.; Diamond, P.; Atkins, G.; Kostakis, P.; Farrugia, A.; Gamble, J.; To, L.; Findlay, D.; Haynes, D.
2005An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factorsZannettino, A.; Farrugia, A.; To, L.; Atkins, G.; Brown, R.; Joy Ho, P.
2003The relationship between RANKL expression and osteoblast differentiation in human osteoblastsKostakis, P.; Atkins, G.; Pan, B.; Farrugia, A.; Gronthos, S.; Evdokiou, A.; Findlay, D.; Zannettino, A.; European Symposium on Calcified Tissues (30th : 2003 : Rome, Italy)